On January 20, 2025, the Tianjin Municipal Bureau of Economy and Information Technology officially released the "Announcement List of the Fourth Batch of Innovative Small and Medium-sized Enterprises in 2024". East-West Analysis Instrument (Tianjin) Co., Ltd. (abbreviation: East-West Analysis) successfully passed the identification of "Innovative Small and Medium-sized Enterprises" and was successfully selected for the list. This is not only a recognition of the continuous innovation ability of "East-West Analysis", but also marks the improvement of its competitiveness and influence in the industry. Innovative small and medium-sized enterprises generally refer to small and medium-sized enterprises that have a sound innovation mechanism, take innovation as the core driving force, form continuous innovation ability in technology, service, management, culture and other aspects, and have a high level of specialization, strong market competitiveness and development potential. is a key element in building a regional innovation development pattern in
Under such strict selection criteria, "East-West Analysis" can stand out due to its long-term high attention and continuous investment in product technology innovation. Since its establishment in 2021, the company has relied on the head office's many years of mass spectrometry technology precipitation and rich medical apparatus management experience, step by step, down-to-earth, not only quickly established a mature medical apparatus quality management system, becoming the first manufacturer in Tianjin to obtain the certificate of microbial identification mass spectrometer medical apparatus; at the same time, it has laid out the market in advance and followed user requests. It has successfully developed a number of top-level projects in China, such as nucleic acid genotyping and mass spectrometry technology, and participated in the drafting of mass spectrometry application industry standards. These achievements not only confirm the keen sense of innovation in East-West analysis, but also demonstrate the profound technical heritage of East-West analysis.
The inclusion in the list of innovative small and medium-sized enterprises in Tianjin is both an honor and a responsibility for East-West Analytics. In the future, "East-West Analytics" will continue to lead by innovation and continuously increase the core competitiveness and market influence of enterprises.
Dongli Analytical Instrument (Tianjin) Co., Ltd. settled in Tianjin Dongli Economic Development Zone International medical apparatus Industrial Park in July 2021, and is a member of Tianjin Life Science and medical apparatus industry technology innovation strategic alliance, a member of Tianjin Biomedical Talent Innovation and Entrepreneurship Alliance and a member of Tianjin Dongli District medical apparatus industry intellectual property alliance.
East-West Analytical Instruments (Tianjin) Co., Ltd. relies on mass spectrometry technology and focuses on the fields of life science and precision medicine. Based on the head office's many years of mass spectrometry technology precipitation and rich experience in medical apparatus management, it has not only quickly established a mature medical apparatus quality management system, but also became the first manufacturer in Tianjin to obtain a microbial identification mass spectrometer. At the same time, it has laid out the market in advance and followed user requests. It has successfully developed a variety of application solutions based on nucleic acid genotyping mass spectrometry technology, which is characterized by high accuracy, low cost, fast detection speed and high throughput. Customized services can be provided according to the specific needs of customers, such as joint detection of multiple pathogens (such as respiratory viruses and bacteria, foodborne pathogens), molecular analysis, drug resistance gene sites and early screening of cancer.
